Regeneron Pharmaceuticals, Inc.
REGN
Revenue
3.79B
▲68.50M▲1.84%
3 Months ChangeAssets
37.76B
▲317.50M▲0.8480%
3 Months ChangeLiabilities
8.41B
▲289.80M▲3.57%
3 Months ChangeFree Cash Flow
1.38B
▲189.20M▲15.91%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-31
Form 10-Q
ID: 0001804220-24-000040
2024-10-31
Form 8-K
ID: 0001804220-24-000038
2024-10-07
Form 8-K
ID: 0001104659-24-106432
2024-08-01
Form 10-Q
ID: 0001804220-24-000028
2024-08-01
Form 8-K
ID: 0001804220-24-000026
2024-07-08
Form 8-K
ID: 0001104659-24-078172
2024-06-20
Form 8-K
ID: 0001104659-24-073372
2024-05-02
Form 10-Q
ID: 0001804220-24-000017
2024-05-02
Form 8-K
ID: 0001804220-24-000015
2024-02-02
Form 8-K
ID: 0001804220-24-000006